A Cambridge-headquartered company developing technology for breast cancer surgery is set to be acquired in a deal worth almost £250 million. Hologic Inc, a global leader in women’s health listed on the US Nasdaq exchange, has signed an agreement to buy Endomagnetics Ltd. Endomag develops and sells breast surgery localisation and lymphatic tracing technologies. Its … Continue reading £247m takeover at Cambridge breast cancer tech firm